Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Take evaluation and safety of smallpox vaccine (LISTER strain) in naïve healthy adults
2005-002175-32Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jun 2005
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of smallpox vaccine lister strain in smallpox, sponsored by Sanofi. Primary endpoint: Vaccination take rate. Started Jun 2005; status: completed.
02
Drugs
smallpox vaccine lister strain
03
Conditions
smallpox
Beyond the preview
Go deeper on 2005-002175-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002175-32.